SEC Filing Summary: PowerUp Acquisition Corp. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by PowerUp Acquisition Corp. (not Aspire Biopharma Holdings, Inc.) on May 22, 2024. The registrant is a Cayman Islands-based special purpose acquisition company (SPAC) listed on The Nasdaq Stock Market LLC. The report details the results of an extraordinary general meeting of shareholders held on May 22, 2024, regarding amendments to the company's charter.
Key Financial Metrics and Liquidity
The filing does not provide standard financial statements, revenue, profit, or cash flow data. Key capital structure and liquidity details include:
- Shares Outstanding: 8,991,229 Class A ordinary shares as of the April 2, 2024 record date.
- Redemptions: 1,226,085 Class A ordinary shares were validly elected for redemption for a pro rata portion of the trust account.
- Net Tangible Assets (NTA): The filing addresses the removal of a requirement mandating at least $5,000,001 in net tangible assets to consummate a business combination.
Material Changes
Shareholders approved two material amendments to the Amended and Restated Memorandum and Articles of Association:
- Extension of Deadline: The date by which the Company must consummate an initial business combination was extended from May 23, 2024, to February 17, 2025.
- Removal of NTA Requirement: The requirement limiting the Company's ability to consummate a business combination if it has less than $5,000,001 in net tangible assets was removed.
Voting Results and Management Commentary
The meeting achieved a quorum with 7,816,061 shares present or represented (86.93% of outstanding shares). The voting results were as follows:
| Proposal | For | Against | Abstain |
|---|---|---|---|
| Extension Amendment | 7,753,807 | 62,254 | 0 |
| NTA Proposal | 7,816,061 | 0 | 0 |
The Adjournment Proposal was not presented as sufficient votes were cast to approve the other proposals. The filing notes that the full text of the amendments is included as Exhibit 3.1.
Investor Verification Checklist
- Verify the new business combination deadline of February 17, 2025, and the implications for the trust account interest accrual.
- Confirm the impact of the 1,226,085 share redemptions on the remaining trust account balance per share.
- Review the implications of removing the $5,000,001 net tangible asset requirement for potential target company valuations.
- Check the definitive proxy statement filed on May 1, 2024, for detailed terms of the amendments.